FMP
General Electric Company
GE
NYSE
General Electric Company, doing business as GE Aerospace, designs and produces commercial and defense aircraft engines, integrated engine components, electric power, and mechanical aircraft systems. It also offers aftermarket services to support its products. The company operates in the United States, Europe, China, Asia, the Americas, the Middle East, and Africa. General Electric Company was incorporated in 1892 and is based in Evendale, Ohio.
198.43 USD
1.02 (0.514%)
Latest GE News
Rayan Ahmad
5 days ago
General Electric's (GE) Impressive Financial Performance in Aerospace
General Electric (NYSE:GE) is a leading global company known for its diverse operations in sectors such as aviation, healthcare, and power. GE Aerospace, a key division, specializes in aviation and aerospace technologies, designing and manufacturing jet engines for commercial and military aircraft. The company competes with other major aerospace firms like Rolls-Royce and Pratt & Whitney. On April 22, 2025, GE reported impressive financial results, with earnings per share (EPS) of $1.49, surpas...
Alex Lavoie
6 days ago
GE Vernova Inc. (NYSE:GEV) Earnings Preview: What to Expect
GE Vernova Inc. (NYSE:GEV) is preparing to release its first-quarter 2025 earnings on April 23. The company, a key player in the renewable energy equipment and services sector, was spun off from General Electric. It focuses on providing energy solutions, including high-efficiency gas turbines. Investors are keenly watching the upcoming earnings report, as it could significantly impact GEV's stock price. Wall Street estimates GEV's earnings per share (EPS) to be $0.45, with revenue projected at ...
Andrew Wynn
Apr 4, 2025
GEO Group, Inc. (NYSE:GEO): A Promising Investment in the Private Corrections Industry
GEO Group, Inc. (NYSE:GEO) is a real estate investment trust (REIT) specializing in the ownership, leasing, and management of correctional, detention, and reentry facilities. The company operates in the United States, Australia, South Africa, and the United Kingdom. GEO competes with other private prison operators like CoreCivic, Inc. and Management & Training Corporation, making it a key player in the private corrections industry. Over the past month, GEO has seen a gain of approximately 5.80%...
Alex Lavoie
Apr 3, 2025
Guess?, Inc. (NYSE: GES) Surpasses Financial Expectations with Strong Earnings and Revenue Growth
Guess?, Inc. (NYSE: GES) is a global fashion brand known for its iconic denim and apparel. The company operates in the retail and wholesale sectors, with a strong presence in Europe and the Americas. GES competes with other fashion giants like Levi Strauss and H&M. Recently, GES reported impressive financial results, showcasing its robust performance in the market. On April 3, 2025, GES reported earnings per share of $1.48, surpassing the estimated $1.41. The company also achieved a revenue of ...
Rayan Ahmad
Apr 2, 2025
Guess?, Inc. (NYSE:GES) Quarterly Earnings Preview
Guess?, Inc. (NYSE:GES) is a well-known global fashion brand that designs, markets, and distributes clothing and accessories. The company is set to release its quarterly earnings on April 3, 2025. Wall Street analysts estimate that the earnings per share (EPS) will be $1.41, with projected revenues of approximately $908 million. The consensus estimate for GES's earnings has recently decreased by 2.7%, now standing at $1.41 per share. This figure represents a significant 29.9% drop compared to t...
Andrew Wynn
Mar 28, 2025
General Electric (NYSE:GE) Maintains Strong Position in Aerospace with Bernstein's "Outperform" Rating
General Electric (NYSE:GE) is a multinational conglomerate known for its diverse operations, including aviation, healthcare, and power. GE Aerospace, a key division, focuses on manufacturing jet engines and providing related services. The company competes with other aerospace giants like Rolls-Royce and Pratt & Whitney. Recently, Bernstein maintained an "Outperform" rating for GE, with the stock priced at $205.88. Bernstein's decision to raise the price target for GE Aerospace from $232 to $250...
Gordon Thompson
Mar 19, 2025
Geron Corporation's Financial Performance in the Biopharmaceutical Sector
Geron Corporation (NASDAQ:GERN) is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for cancer treatment. The company invests heavily in research and development, which is typical for firms in this sector. This often results in a negative Return on Invested Capital (ROIC) as they work towards bringing their products to market. Geron's ROIC is -34.35%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 8.21%. This indicates t...
Davit Kirakosyan
Mar 18, 2025
Getty Images Rises on Strong Q4 Earnings, But 2025 Outlook Disappoints
Getty Images Holdings (NYSE:GETY) saw its shares rise over 1% intra-day today after delivering better-than-expected fourth-quarter earnings, fueled by robust editorial revenue growth and higher annual subscription contributions. However, guidance for 2025 fell short of analyst expectations, tempering some of the enthusiasm. The company reported adjusted earnings per share of $0.06, beating forecasts of $0.05, while revenue rose 9.5% year-over-year to $247.3 million, surpassing the expected $245....
Alex Lavoie
Mar 17, 2025
Getty Images Holdings, Inc. (NYSE: GETY) Surpasses Earnings Estimates
Getty Images Holdings, Inc. (NYSE: GETY) is a prominent player in the global visual content industry, providing a vast marketplace for images and videos. On March 17, 2025, GETY reported earnings per share (EPS) of $0.06, surpassing the estimated $0.04. The company also achieved a revenue of approximately $247.3 million, slightly exceeding the estimated $246.3 million. In the fourth quarter of 2024, Getty Images experienced a 9.5% revenue growth, with a currency-neutral growth of 8.5%. This gro...
Stuart Mooney
Mar 11, 2025
Geron Corporation's Financial Analysis in the Competitive Biopharmaceutical Landscape
Geron Corporation (NASDAQ:GERN) is a biopharmaceutical company focused on developing and commercializing innovative therapeutics for cancer treatment. The company's primary product candidate is imetelstat, a telomerase inhibitor, which is in clinical trials for hematologic myeloid malignancies. Geron operates in a competitive landscape with peers like Stem, Inc., Agenus Inc., and Exelixis, Inc., each with varying degrees of capital efficiency. Geron Corporation's financial metrics reveal a chal...
